ATLASAytu BioPharma (AYTU) earnings date: Nov 12, 2026
Aytu BioPharma (AYTU) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 12, 2026. Analysts expect EPS of -$0.10.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on AYTU
| Last price | $1.93 (-2.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±2.7% |
| Earnings beat history | Beat the EPS estimate in 5 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Aytu BioPharma stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Aytu BioPharma reports on Nov 12, 2026. One email the day before, with ATLAS’s read on Aytu BioPharma. You can switch it off at any time.
Alert me before AYTU reportsFree to start. Creating an account takes under a minute.
Notify me when Aytu BioPharma reports
Track AYTU free Add Aytu BioPharma to a free ATLAS watchlist and see its next report date in one place.
AYTU earnings at a glance
| Next report (confirmed) | Thu, Nov 12, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.10 |
| Last report | Sep 22, 2026 · Beat |
| Beat rate (last 5 reports) | 5 of 5 (100%) |
| Average EPS surprise | +28.2% |
| Average move around a report | ±5.3% (last 5) |
| Sector | Healthcare · Drug Manufacturers - Specialty & Generic |
Aytu BioPharma earnings history: last 5 reports
Aytu BioPharma last reported on Sep 22, 2026: EPS of -$0.05 against an estimate of -$0.22 (+77.3% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Sep 22, 2026 | -$0.22 | -$0.05 | +77.3% | Beat | +7.0% |
| May 13, 2026 | -$0.42 | -$0.41 | +2.4% | Beat | -1.3% |
| Apr 28, 2026 | $4.82 | $4.97 | +3.1% | Beat | -1.6% |
| Feb 3, 2026 | -$0.49 | -$0.23 | +53.1% | Beat | -13.3% |
| Jan 15, 2026 | $2.98 | $3.14 | +5.4% | Beat | -3.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for AYTU
See the fair value, the probability range and the earnings history of Aytu BioPharma on its ATLAS page.
Aytu BioPharma (AYTU) stock analysisPlans from €3.99 a month.
Aytu BioPharma earnings: frequently asked questions
When does Aytu BioPharma (AYTU) report earnings?
Aytu BioPharma is scheduled to report on Thursday, November 12, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for AYTU?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.10 per share (USD). Estimates can change before the report.
How often does AYTU beat earnings estimates?
Of its last 5 reports with a recorded result, Aytu BioPharma beat the EPS estimate 5 times; the average surprise was +28.2%. Past results do not predict the next one.
How much does AYTU move around earnings?
Over its last 5 reports the stock moved an average of 5.3% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did Aytu BioPharma beat earnings estimates last quarter?
Aytu BioPharma last reported on Sep 22, 2026: EPS of -$0.05 against an estimate of -$0.22 (+77.3% surprise), a beat.
How much does AYTU usually move in a day?
On a normal trading day the ATLAS model puts AYTU’s one-day range at about ±2.7%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 12, 2026
Educational information, not investment advice. Disclaimer